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Abstract
Background: Upper airway inflammation has been previously demonstrated in obstructive sleep apnea (OSA). However,
investigation has been hampered by the necessity of invasive tissue biopsies.
Objective: To evaluate the pharyngeal lavage (PHAL) as a new tool to analyze mucosal inflammation in the pharynx of
patients with sleep-related disordered breathing.
Patients and Methods: 36 patients with a diagnosis of OSA, 14 patients with heavy snorer syndrome (HS) or body position
dependent OSA (bd-OSA), and 14 healthy volunteers underwent PHAL. Inflammatory cell counts were compared.
Results: Neutrophils were the predominant cells in PHAL in all groups (94.3%60.7%, 98.5%60.6%, 94.3%60.7%, and
96.2%61.4%). OSA patients had significantly increased numbers of lymphocytes (3.2%60.4%) compared to bd-OSA/HS and
controls group (0.5%60.1% and 0.6%60.2%, respectively; P,0.05). Patients with moderate to severe OSA had significantly
higher numbers of lymphocytes compared to patients with mild OSA (P,0.05).
Conclusions: Data from this study suggest that PHAL is a feasible tool to investigate upper airway inflammation in OSA. In
addition, PHAL demonstrates lymphocytic inflammation of the pharynx in OSA patients. Future studies are warranted to
evaluate whether PHAL can be used to monitor disease and whether lymphocytic inflammation is affected by OSA
treatment.
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Introduction
Obstructive sleep apnea (OSA) is a common disorder in the
Western World affecting 4% of all men and 2% of all women [1].
Recurrent collapse of the upper airways during sleep causes
recurrent hypopnea and apnea resulting in hypoxaemia, arrhyth-
mia and rise of blood pressure as well as arousal. OSA has been
shown to be associated with cardiac and vascular diseases [2–4].
Endothelial dysfunction and systemic inflammation are considered
as important underlying pathophysiologic conditions [5,6].
In addition to systemic inflammation previous studies including
work from our own laboratory have demonstrated local inflam-
mation in the upper airway mucosa of patients with OSA [7–9].
Leukocyte numbers are increased in the mucosa of both pharynx
and nose [7,8]. It is unclear whether this inflammation is due to an
intrinsic factor in the pathogenesis of OSA or due to mechanical
stress caused by repetitive collapse of the airways. The present
hypothesis favours stress-induced inflammation [10]. Recent
experiments with an animal model of recurrent collapse of the
airways further support this hypothesis [11].
Until recently investigations of local inflammatory processes in
the upper airway mucosa in OSA patients were hampered by the
need to perform invasive tissue biopsies. These biopsies are
uncomfortable for the patient especially when taken at different
time points. Moreover, biopsies may also cause serious side effects
(eg. bleeding, infection). We recently reported a new method for
non-invasive examination of inflammatory cells in the pharynx,
the so called pharyngeal lavage (PHAL) [9].
The intermediate collapsibility of the nonapneic’s upper airways
relative to healthy controls and OSA patients has led to the concept
that snoring and OSA are part of a spectrum of sleep-related
breathing disorders. About 10% of all snorers have OSA [12].
Since there is a difference in leukocyte numbers between healthy
controls and OSA patients [7,9] we wondered whether lymphocyte
counts would be elevated in snoring patients or patients with body
position-dependent OSA (bd-OSA). We hypothesized that local
inflammation may be also present but show lower intensity snorers
and patients with bd-OSA. We speculated that local inflammation
may develop with increasing severity of sleep-related disordered
breathing and upper airway collapse. To test this hypothesis PHAL
was performed to analyze local inflammation of the upper airways in
patients with OSA, bd-OSA/snoring patients and in healthy controls.
Materials and Methods
Patients and controls
36 patients with a diagnosis of OSA, 14 patients with heavy
snorer syndrome or body position dependent OSA (bd-OSA), and
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approval was obtained by the ethics committee of the university
of Lu ¨beck. Verbal informed consent was obtained from all patients
and volunteers. This was documented in written form in
accordance with ethical guidelines of the local ethics committee.
Part of the study population was already used for analysis in
another publication (14 patients with OSA and 11 controls, 9).
Table 1 summarizes the demographics of the patient groups and
the controls. Healthy controls did not undergo standard
polysomnography (PSG) and none had reported sleep-related
breathing disorders. Patients with severe concomitant disease (eg.
heart failure, liver failure, kidney failure), acute or chronic
inflammatory disease of the airways or use of drugs that can
affect sleep (eg. sedatives, anxiolytics, illegal drugs) were excluded
from the study. Controls and patients were non-smokers. Severity
of OSA was classified according to the RDI (respiratory distress
index): RDI 5-10/h mild, RDI 11-15/h moderate, RDI .15/h
severe. Patients were classified as having body position-dependent
OSA if the RDI was .5/h in supine position and ,5/h in any
other body position. Patients were classified as heavy snorers (HS)
if the snoring index was .20/h and if obstructive hyponeas/
apneas were present only in supine position or RDI ,5/h [13,14].
Pharyngeal lavage
Pharnygeal lavage (PHAL) was performed in the morning after
waking up. Patients and controls rinsed their mouth with sterile
saline at room temperature. After that they gargled with 50 ml of
sterile saline in several fractions for 5 to 10 sec each. Patients and
controls spit the saline in to a sterile container for sample
collection. Samples underwent centrifugation with 1500 RPM for
10 min. The cell pellet was resuspended into sterile saline and
cytospins were made (centrifugation for 750 RPM for 5 min).
Cytospins were stained with Hemacolor fast stain (Merck,
Darmstadt, Germany) for further analysis.
Cell count and differential cell count
Squamous cells that represented the largest quantity of cells on
the cytospins were not further included into analysis. 200 to 400
inflammatory cells were counted per cytospins for differential cell
counts. Counting was performed by two experienced investigators
without blinded to clinical data. The within-observer coefficient of
variation for repeated measures was less than 5%.
Statistical analysis
The difference in the number of inflammatory cells between the
groups were compared with the nonparametric Kruskal-Wallis
test. Statistically significant differences between groups were
subsequently analyzed with the Mann-Whitney U test (Systat
version 7.0; SPSS, Chicago, Ill). Results are expressed as
means6SEM and are significant at a P value of less than .05.
Results
Characterization of patients and controls
Table 1 summarizes the demographics in the different groups.
There was a significant difference in the RDI (respiratory distress
index), in the ODI (oxygen desaturation index) and in the Epworth
sleepiness scale score between OSA patients and bd-OSA
patients/HS (P,0.05).
Inflammatory cell counts in the pharyngeal lavage
As expected squamous cells represented the majority of cells in
the PHAL. They were not further analyzed because they were
most probably shed from the airways while performing the PHAL.
Neutrophils were the most prominent inflammatory cells in all
three groups. Figure 1 shows original microscopic images of
PHAL. The numbers of neutrophils were significantly higher in
the bd-OSA/HS group compared to the OSA group
(98.5%60.6% vs 94.3%60.7%; P,0.05). There was no signifi-
cant difference compared to the control group (96.2%61.4%;
P.0.05) (Fig. 2A). The numbers of lymphocytes were significantly
increased in the OSA group (3.2%60.4%) compared to the bd-
OSA/HS and compared to the control group (0.5%60.1% and
0.6%60.2%, respectively) (P,0.05) (Fig. 2B). The percentage of
macrophages was significantly lower in the bd-OSA/HS
(0.9%60.5%) compared to the control group and to the OSA
group (2.9%61.2% and 1.9%60.3%, respectively) (P,0.05).
There was no significant difference in the numbers of eosinophils
between the three groups (control: 0.4%60.2%, bd-OSA/HS:
0.2%60.2%, OSA: 0.4%60.2%) (P.0.05).
Lymphocytes and severity of sleep-related breathing
disorders
The numbers of lymphocytes were significantly increased in the
OSA patients with moderate and severe disease (3.9%60.8% and
3.2%60.6%, respectively) compared to patients with mild disease
(1.5%60.3%) (P,0.05). There was no statistically significant
difference between patients with moderate and severe disease
(P.0.05). The percentage of lymphocytes was significantly higher
in patients with OSA than in patients with bd-OSA or HS
regardless of the severity of OSA (P,0.05) (Fig. 3). However, no
significant correlation between lymphocytes and the severity of
OSA was observed (P.0.05).
Discussion
In the present study PHAL was used to evaluate local
inflammation in the upper airways of patients with OSA, bd-
OSA patients/HS and healthy controls. We found significantly
increased numbers of lymphocytes in patients with OSA compared
to both patients with bd-OSA/HS and healthy controls.
Information on airway inflammation and inflammatory cell in
the airway mucosa in patients with sleep apnea is sparse [7,15].
Studies by Sekosan and co-workers and by Boyd and colleagues
demonstrated leukocyte infiltration and lymphocytic inflamma-
tion in the mucosa of patients with OSA [7,15]. In our study we
also found increased numbers of lymphocytes in OSA patients.
While the above mentioned studies only compared OSA and
healthy controls we also analyzed the PHAL of patients with bd-
OSA and HS. Interestingly, there was no significant difference in
Table 1. Demographic characteristics of patient groups and
controls.
OSA bd-OSA/HS Control
Number (male/female) 36 (26/10) 14 (12/2) 14 (5/9)
Mean age (years) 52.162.1 49.462.2 31.864.7
Mean RDI 33.463.6 19.363.3* n. d.
Mean ODI 28.863.8 15.963.5* n. d.
Mean ESS-Score 18.561.4 12.361.9* n. d.
OSA: Obstructive sleep apnea. Bd-OSA: body-dependent OSA. HS: heavy snorer.
RDI: respiratory distress index. ODI: oxygen desaturation index. ESS: Epworth
sleepiness scale.
*: P,0.05 vs OSA.
doi:10.1371/journal.pone.0016277.t001
Pharyngeal Lavage in OSA
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patients with bd-OSA/HS. Thus bd-OSA and heavy snoring
may be a different entity from OSA or they may represent the
first early stages of a disease process leading eventually to OSA.
To our knowledge our study is the first to investigate and
compare upper airway inflammation by PHAL in these three
groups.
At present it is not clear whether local inflammation in OSA is
the cause of pharyngeal collapse or whether it results from this. A
recent study in an animal model of cycling airway collapse
supports the hypothesis that mechanic traumata due to airway
collapse lead to mucosal inflammation [11]. If snoring is
considered as a first step in the development of OSA our data
agree with those studies and imply that development of
lymphocytic mucosal inflammation may be a crucial factor.
Another possibility is that snoring and OSA represent different
ends of a spectrum of sleep-related breathing disorders. Long term
follow-up studies of snorers may help to clarify this point.
Figure 1. Microscopy of pharyngeal lavage showing neutrophils (A) and squamous cells and lymphocytes (B). Hemacolor fats stain.
Original magnification x400.
doi:10.1371/journal.pone.0016277.g001
Figure 2. Numbers of neutrophils (A) and other inflammatory cells (B) in the pharhygeal lavage differential cell counts from
controls and patient groups. Bars represent mean values+SEM. OSA: obstructive sleep apnea. Bd-OSA: body position dependent-OSA. HS: heavy
snorer. *: P,0.05 vs OSA. +:P ,0.05 vs control.
doi:10.1371/journal.pone.0016277.g002
Pharyngeal Lavage in OSA
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Moreover, we only used percentages of inflammatory cells and
ignored squamous cells. However, in bronchoalveolar lavage a
widely used and accepted technique the differential cell counts and
the percentage of inflammatory cells provides the most important
information on inflammation.
One major point of weakness of the study is that no tissue
biopsies were obtained for histologic examination and verification
of tissue inflammation. Tissue biopsies are potentially harmful for
the patient. Our aim was to investigate whether a non-invasive
method could detect local inflammation in the upper airways in
patients with sleep-related disordered breathing. Previous exper-
iments in our own lab showed that differential cytology in PHAL
correlated well with inflammatory cell profiles in mucosal biopsies
(unpublished observation). Taking into account previous data from
the literature that demonstrated increased numbers of leucocytes
in the airway mucosa of patients with OSA [7] we think that
PHAL indeed reflects local airway inflammation.
In conclusion the present study describes PHAL as a new tool to
investigate mucosal inflammation of the upper airways in patients
with obstructive sleep apnea. In addition, the present data
demonstrate that lymphocytic inflammation is present in the
pharyngeal muocsa in OSA but not in bd-OSA/HS. Future
studies are warranted to evaluate whether PHAL can be used to
monitor disease and whether lymphocytic inflammation of the
upper airways is affected by treatment with continous positive
airway pressure (CPAP).
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